Factors governing development of nonalcoholic fatty liver disease and insulin resistance in obesity

Vulf M.A.1, Kirienkova E.V.1, Skuratovskaia D.A.1, Levada E.V.1, Volkova L.V.1, Zatolokin P.A.2, Gazatova N.D.1, Litvinova L.S.1

1. Immanuel Kant Baltic Federal University, Kaliningrad, Russia
2. Immanuel Kant Baltic Federal University, Kaliningrad, Russia; Regional Clinical Hospital of the Kaliningrad Region, Kaliningrad, Russia
Section: Clinical and Diagnostic Research
DOI: 10.18097/PBMC20186405444      PubMed Id: 30378562
Year: 2018  Volume: 64  Issue: 5  Pages: 444-450
The factors promoting development of non-alcoholic fatty liver disease in patients with obesity and different state of carbohydrate metabolism have been studied. 43 patients were examined; these included 26 patients with abdominal obesity (BMI=52.9±7.9 kg/m2). The control group consisted of 17 conditionally healthy donors without obesity (BMI=18.9-24.9 kg/m2), seven of them formed a comparison group that was included to compare the results of study on the levels of tissue-specific expression of HSP70 mRNA. The study of mRNA expression was performed by real-time PCR. The concentration of IL-6 and TNF-a was measured in blood serum by the ELISA method. In patients with obesity with diabetes mellitus type 2 (DM2), a significant increase in the serum level of proinflammatory cytokines was found in comparison with the group of patients without DM2 and control. The results of histological examination of liver biopsy specimens in obese patients revealed the most pronounced changes in the group of DM2 patients. Regardless of the stage of nonalcoholic fatty liver disease in obese DM2 patients, an increase in the area of fatty inclusions (relative to the group without type 2 diabetes) was recorded. The study of the HSP70 gene expression in peripheral blood mononuclear cells allowed its significant increase relative to the comparison group. The relationship between the level of expression of the HSP70 gene in metabolically active tissues (visceral, subcutaneous adipose tissue and liver) established in all obese patients with the serum content of proinflammatory cytokines (IL-6 and TNF-a) may indicate suppression of HSP70 expression in these tissues, background of systemic and local inflammation in obesity.
Download PDF:  
Keywords: obesity, insulin resistance, non-alcoholic fatty liver disease, fat tissue, liver biopsy, expression of HSP70

Vulf, M. A., Kirienkova, E. V., Skuratovskaia, D. A., Levada, E. V., Volkova, L. V., Zatolokin, P. A., Gazatova, N. D., Litvinova, L. S. (2018). Factors governing development of nonalcoholic fatty liver disease and insulin resistance in obesity. Biomeditsinskaya Khimiya, 64(5), 444-450.
This paper is also available as the English translation: 10.1134/S1990750819010128
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)